Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

April 24, 2021

Study Completion Date

June 3, 2021

Conditions
Health
Interventions
DRUG

Apixaban 5 mg Film-Coated Tablet (produced by PT Dexa Medica)

One tablet of the test drug was given orally under fasting condition

DRUG

Eliquis® 5 mg film-coated tablet (Bristol-Myers Squibb Company, Puerto Rico, packed and released by Bristol-Myers Squibb S.r.l., Italy, imported by PT Pfizer Indonesia)

One tablet of the reference drug was given orally under fasting condition

Trial Locations (1)

Unknown

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PT Equilab International

INDUSTRY

lead

Dexa Medica Group

INDUSTRY

NCT06817811 - Bioequivalence Study of Apixaban 5 mg Film-Coated Tablet | Biotech Hunter | Biotech Hunter